Compare Aurora Cannabis Inc (ACB) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aurora Cannabis Inc vs Newmont Corporation — how do they compare? Aurora Cannabis Inc trades at $3.49 (market cap $178.92M), while Newmont Corporation trades at $118.27 (market cap $123.56B). The key difference: Newmont Corporation is far larger — about 690.6× Aurora Cannabis Inc's market cap, and Newmont Corporation pays a 0.89% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | NEM | |
|---|---|---|
Market Cap | $178.92M | $123.56B |
Sector | Health | Basic Materials |
52-Week High | $6.23 | $131.95 |
52-Week Low | $2.58 | $67.38 |
Enterprise Value | $123.48M | $120.14B |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.99, up 0.34% with a bullish technical signal despite mixed earnings. The company achieved record annual medical cannabis revenue growth of 18% YoY to $288.6 million in FY2026, but faces margin pressure from Canadian reimbursement changes. Recent Q1 2027 earnings beat expectations with $0.04 EPS versus -$0.13 estimate, though revenue declined to $67.6 million. The stock shows strong institutional support with shareholder approval of board measures and EU-GMP certification for international expansion.
ACB presents a high-risk opportunity with significant volatility. While international medical cannabis growth and operational improvements provide upside potential, persistent net losses, negative ROE/ROA, and Canadian market challenges create substantial headwinds. Analyst consensus remains cautious with only 21% buy ratings, reflecting concerns about profitability timeline and competitive pressures in the evolving cannabis sector.
Newmont Corporation (NEM) trades at $112.98, up 7.16% over 24 hours, reflecting strong momentum amid record gold prices. The stock exhibits bullish technical signals with moving averages aligned positively, though oscillators suggest overbought conditions. Fundamentally, the company reported robust earnings, with Q2 2026 EPS of $2.10 beating estimates, and annual revenue growth from $11.9B in 2022 to $22.7B in 2025. Recent news highlights a $1.95B settlement with Barrick Mining, resolving Nevada disputes and enhancing strategic flexibility.
Outlook remains positive with a consensus price target of $133, implying 17.8% upside, supported by 75.7% analyst buy ratings. Key opportunities include strong free cash flow generation and production guidance maintenance. Risks involve potential cost pressures in H2 2026, gold price volatility, and insider stock sales by the CEO and CFO in early August 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
